Back to Journals » Drug Design, Development and Therapy » Volume 15

A Novel Bispecific Immunotoxin Delivered by Human Bone Marrow-Derived Mesenchymal Stem Cells to Target Blood Vessels and Vasculogenic Mimicry of Malignant Gliomas [Retraction]

Authors Zhang Y, Sun X, Huang M, Ke Y, Wang J, Liu X

Received 31 August 2021

Accepted for publication 31 August 2021

Published 2 September 2021 Volume 2021:15 Pages 3733—3734

DOI https://doi.org/10.2147/DDDT.S336973

Download Article [PDF] 

Zhang Y, Sun X, Huang M, Ke Y, Wang J, Liu X. Drug Des Devel Ther. 2015;9:2947–2959.

At the request of the authors, the Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. Concerns were raised regarding duplicated mouse images and cell staining images in Figures 4A and 5A, respectively. The authors were unable to locate the original data for their study and thus were unable to verify the validity of the data. To ensure the integrity of the publication record the authors requested to retract the paper and the editor has agreed with this decision.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]